MetLife Investment Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,893
| Closed | -$25.4K | – | 2859 |
|
|
2025
Q1 | $25.4K | Sell |
15,893
-12,961
| -45% | -$20.7K | ﹤0.01% | 2737 |
|
|
2024
Q4 | $104K | Sell |
28,854
-6,601
| -19% | -$23.8K | ﹤0.01% | 2605 |
|
|
2024
Q3 | $202K | Buy |
35,455
+19,978
| +129% | +$114K | ﹤0.01% | 2282 |
|
|
2024
Q2 | $71.5K | Buy |
+15,477
| New | +$71.5K | ﹤0.01% | 2704 |
|
|
2023
Q2 | – | Sell |
-27,475
| Closed | -$86.3K | – | 2947 |
|
|
2023
Q1 | $86.3K | Hold |
27,475
| – | – | ﹤0.01% | 2609 |
|
|
2022
Q4 | $162K | Hold |
27,475
| – | – | ﹤0.01% | 2377 |
|
|
2022
Q3 | $241K | Buy |
27,475
+6,363
| +30% | +$55.8K | ﹤0.01% | 2162 |
|
|
2022
Q2 | $159K | Hold |
21,112
| – | – | ﹤0.01% | 2457 |
|
|
2022
Q1 | $512K | Buy |
21,112
+7,792
| +58% | +$189K | ﹤0.01% | 1762 |
|
|
2021
Q4 | $429K | Hold |
13,320
| – | – | ﹤0.01% | 1588 |
|
|
2021
Q3 | $595K | Hold |
13,320
| – | – | 0.01% | 1426 |
|
|
2021
Q2 | $504K | Buy |
13,320
+7,972
| +149% | +$302K | ﹤0.01% | 1564 |
|
|
2021
Q1 | $198K | Hold |
5,348
| – | – | ﹤0.01% | 2055 |
|
|
2020
Q4 | $177K | Buy |
+5,348
| New | +$177K | ﹤0.01% | 2039 |
|